Victory Capital Management Inc. Sells 405,240 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Victory Capital Management Inc. lowered its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 19.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,662,668 shares of the company’s stock after selling 405,240 shares during the period. Victory Capital Management Inc. owned approximately 3.37% of Prestige Consumer Healthcare worth $129,838,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC raised its holdings in shares of Prestige Consumer Healthcare by 3.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after buying an additional 49,331 shares during the period. Geode Capital Management LLC grew its position in Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after acquiring an additional 50,961 shares during the last quarter. Congress Asset Management Co. increased its stake in Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after purchasing an additional 43,619 shares during the period. Boston Trust Walden Corp lifted its position in shares of Prestige Consumer Healthcare by 43.5% during the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock worth $64,942,000 after purchasing an additional 252,089 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 5.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company’s stock valued at $49,667,000 after purchasing an additional 33,844 shares during the period. Institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Canaccord Genuity Group upped their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a report on Monday, December 9th. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Finally, DA Davidson increased their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH opened at $85.67 on Thursday. The firm has a 50 day moving average of $80.43 and a 200 day moving average of $77.57. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $4.24 billion, a price-to-earnings ratio of 20.06, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.